NCT07209527Enrolling by invitationEarly phase 1
Truway Diagnostic Tools in Primary Care
Evaluation of Truway Health-Sourced Portable Diagnostic Devices for Early Detection of Chronic Conditions in Outpatient Primary Care Settings: A Prospective Interventional Study
Source: ClinicalTrials.gov · Last updated 5 Nov 2026
Brief summary (registry, in English)
This study evaluates the effectiveness of Truway Health-sourced portable diagnostic devices, including ultrasound and blood glucose monitors, in early detection of chronic conditions in outpatient primary care settings. Conducted as a prospective interventional trial, 200 participants will be assigned to use these devices versus standard care over a 6-month period. The primary outcome is improved diagnostic accuracy and patient outcomes. The study, led by Truway Health, Inc., aims to enhance accessible healthcare solutions starting at a New York site, with potential expansion to Miami.
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 1 Oct 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Oct 2028
- Lead sponsor
- Truway Health, Inc.
- NCT number
- NCT07209527
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 200
- From 1 Oct 2025 to the primary completion date, 1 Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known hypersensitivity to any components of the investigational intervention
- Uncontrolled or unstable comorbid conditions (for example, cardiovascular, hepatic, renal, or psychiatric disorders)
- Cognitive impairment or language barrier that would preclude valid informed consent or reliable reporting
Other
- Pregnancy or breastfeeding at the time of enrollment
- Participation in another interventional clinical trial within the past 3 months
- \-
Who the study is looking for
- Age 18 to 75 years, inclusive
- Ability to understand the study procedures and provide written informed consent
- Diagnosis of the target condition according to established clinical or diagnostic criteria
- Stable treatment regimen (pharmacologic or non-pharmacologic) for at least 4 weeks prior to screening
- Willingness and ability to comply with all study visits, procedures, and follow-up assessments -
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Truway Health, Inc. Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.